This site is intended for health professionals only

UCB successfully completes its fixed rate bonds


UCB SA/NV announces today that it has successfully completed the placement of its 5.75% fixed rate bonds through a public offering in Belgium and Luxembourg.

The offer period has been early terminated on October 27, 2009 at 5:30 pm. The aggregate nominal amount of the bonds has been set at €750 million.

The net proceeds from the issue of the bonds will be used by UCB for general corporate purposes and form part of UCB’s funding diversification policy.

The payment date will be November 27, 2009.

BNP Paribas Fortis, ING and KBC Bank act together as lead managers for this transaction.

The bonds will be listed on the Luxembourg Stock Exchange.

Detlef Thielgen, CFO of UCB, said: “We are very pleased with the strong support UCB receives in Belgium and Luxembourg and together with the recent convertible bond issuance, this operation confirms our ability to access various international Capital Markets.


Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine